Related Experiment Video
Updated: Apr 11, 2026

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics
Published on: September 16, 2022
Pilot study on novel skin care method by augmentation with Staphylococcus epidermidis, an autologous skin microbe--A
Yuichi Nodake1, Saki Matsumoto2, Ryoko Miura2
1Department of Biochemistry, Faculty of Pharmaceutical Sciences, Nagasaki International University, 2825-7 Huis Ten Bosch, Sasebo, Nagasaki 859-3298, Japan.
Background And Objective:
Staphylococcus epidermidis is an autologous bacterium that is beneficial to skin health. Our goal was to develop a novel, personalized basic cosmetic that exploits this characteristic.
Methods:
We conducted a double-blinded, randomized clinical trial on augmentation with S. epidermidis as a pilot study, in which S. epidermidis was collected from the subject, cultured for proliferation, and then continuously applied to the subject's own face before sleep twice per week for four weeks in order to increase colonization levels.
Results:
The results showed that this treatment increased the lipid content of the skin and suppressed water evaporation, thereby markedly improving skin moisture retention. Moreover, augmentation with S. epidermidis maintained a low acidic condition on the skin surface. The low risk of undesirable effects induced by augmentation with S. epidermidis was also confirmed by measuring erythema and melanin levels.
Conclusions:
These results may serve as a driving force to accelerate the development of novel, personalized basic cosmetics.
More Related Videos
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
Staphylococcal Skin Infections
The Skin Microbiota
Renewal of Skin Epidermal Stem Cells

